Skip to content

Clinical trials

Respiratory Syncytial Virus Infections trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Syncytial Virus Infections Country / region: Spain Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20141
20153
20161
20173
20182
20195
20202
20215
20222
20236
20245
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Terminated6
Active, not recruiting2
Recruiting2
Unknown status2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline17
AstraZeneca3
Enanta Pharmaceuticals, Inc2
Janssen Research & Development, LLC2
Janssen Sciences Ireland UC2
MedImmune LLC2
Abbott1
Ablynx, a Sanofi company1
Federico Martinón Torres1
Hospital Clinico Universitario de Santiago1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Syncytial Virus Infections38
Arrhythmias, Cardiac1
Asthma1
COVID-191
Cytokine Release Syndrome1
Death1
Infections1
Influenza, Human1
Lung Diseases1
Pneumonia1

Trials

Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.